Sanjay Shukla - 28 Jul 2023 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Signature
/s/ Nancy E. Denyes, Attorney-in-Fact
Issuer symbol
LIFE
Transactions as of
28 Jul 2023
Transactions value $
$30,224
Form type
4
Filing time
01 Aug 2023, 16:07:02 UTC
Previous filing
21 Feb 2023
Next filing
13 Nov 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common Stock Purchase $30,224 +15,000 +24.5% $2.01 76,173 28 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents weighted average price for the shares. The shares were purchased at prices ranging from $2.01 to $2.02 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price